Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Prospex Eng Share Price
  4. Prospex Eng Share Regulatory News
  5. Updated Corporate Presentation

Pin to quick picksProspex Eng Regulatory News (PXEN)

Prospex Eng Information

Share Price Information for Prospex Eng (PXEN)

Share Price is delayed by 15 minutes
Get Live Data
3.10    0.00 (0.00%)
Bid:
2.90
Ask:
3.30
Spread: 0.40 (13.793%)
Market Cap: £13.45m
PXEN Live PriceLast checked at - London Stock Exchange

Intraday Prospex Eng Share Chart

Updated Corporate Presentation

15 Apr 2024 07:00

RNS Number : 5114K
Prospex Energy PLC
15 April 2024
 

Prospex Energy PLC / Index: AIM / Epic: PXEN / Sector: Oil and Gas

 

 

15 April 2024

 

Prospex Energy PLC

('Prospex' or the 'Company')

 

Updated Corporate Presentation

 

Prospex Energy PLC, the AIM quoted investment company focused on European gas and power projects, is pleased to announce that an updated corporate presentation can be viewed on the Company's website: www.prospex.energy. The presentation has been updated to reflect recent news including the fact that on 27 March 2024, the Company announced that it had settled the third and final capital repayment from the Convertible Loan Notes issued in September 2022 and is now completely debt-free.

 

* * ENDS * *

 

 

For further information visit www.prospex.energy or contact the following:

 

 

Mark Routh

Prospex Energy PLC

Tel: +44 (0) 20 7236 1177

Ritchie BalmerRory Murphy

Strand Hanson Limited

Tel: +44 (0) 20 7409 3494

Lional Therond / Daniel Fox-Davies

 

 

Fox-Davies Capital Limited

Tel: +44 (0) 20 3884 8450

Andrew Monk (Corporate Broking)Andrew Raca/Alex Cabral (Corporate Finance)

VSA Capital Limited

Tel: +44 (0) 20 3005 5000

Ana Ribeiro / Susie Geliher

St Brides Partners Limited 

Tel: +44 (0) 20 7236 1177

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKLAFFELEFA
123456
Date   Source Headline
1st Jun 20267:00 amRNSStrategic Collaboration with IMMAGE
28th May 20267:00 amRNSFinal Results & Notice of AGM
15th May 20267:00 amRNSQ1 2026 Overview &Unaudited Group Financial Update
7th May 20267:00 amRNSBoard Changes
30th Apr 20267:00 amRNSItaly Selva Malvezzi - Q1 2026 Activity Report
22nd Apr 20267:00 amRNSDunajec Licence Award, Poland
1st Apr 20267:00 amRNSSan Licence Award, Poland
26th Mar 20262:50 pmRNSCorporate Update & New Corporate Presentation
24th Mar 20267:00 amRNSFormal Offer of onshore Polish licences
18th Mar 20267:00 amRNSTotal CLN Funding Reaches £2m, 25% Above Target
17th Mar 202610:30 amRNSConversion of Loan Notes and TVR
13th Mar 20267:00 amRNSUpdate: £1.6 million CLN Fundraise Oversubscribed
13th Mar 20267:00 amRNSUpdate: £1.6 million CLN Fundraise Oversubscribed
12th Mar 20267:00 amRNSLetter to Shareholders and IMC Investor Event
16th Feb 20267:00 amRNSTarba - El Romeral Production Re-start
2nd Feb 20267:00 amRNSCEO takes up post
28th Jan 20267:00 amRNSItaly: Selva Malvezzi Production Concession
22nd Jan 20267:00 amRNSRental of Transformer at El Romeral
19th Jan 20267:00 amRNSCompletion of Convertible Loan Notes Fundraise
12th Jan 20267:00 amRNSUpdate: Convertible Loan Notes Fundraise
6th Jan 20267:00 amRNSSenior Management Changes: Appointment of New CEO
19th Dec 20257:00 amRNS£565,000 Issuance of Convertible Loan Notes
19th Dec 20257:00 amRNS£565,000 Issuance of Convertible Loan Notes
4th Dec 20257:03 amRNSItaly: Selva Malvezzi – Operational Update
24th Nov 20257:00 amRNSThird Quarter Unaudited Group Financial Update
20th Nov 202511:51 amRNSViura Operational Update
18th Nov 20257:31 amRNSItaly: Selva Malvezzi Production Concession Update
17th Nov 20257:00 amRNSCompletion of Statutory EIA Consultation Process
31st Oct 20257:00 amRNSItaly: Selva Malvezzi - Q3 2025 Activity Report
24th Oct 20257:00 amRNSPlateau Production Rates confirmed at Viura Field
22nd Oct 20257:00 amRNSProspex Advances European Growth Strategy
20th Oct 20257:00 amRNSProduction Restarts at Viura Field
17th Sep 20257:00 amRNSViura Field Update
10th Sep 20257:00 amRNSHalf-year Report
26th Aug 20257:00 amRNSViura Field Update
21st Aug 20257:00 amRNSSigning Gas Sales Agreement with Hera Group
31st Jul 20257:00 amRNSOperational Update
30th Jun 20257:00 amRNSResult of Retail Offer and Additional Subscription
27th Jun 20257:00 amRNSWRAP Retail Offer Still Open
25th Jun 20251:01 pmRNSResult of AGM
25th Jun 20257:01 amRNSWRAP Retail Offer for up to £500,000
25th Jun 20257:00 amRNSResult of oversubscribed Placing and Subscription
24th Jun 20255:08 pmRNSProposed Placing & Subscription and Retail Offer
20th Jun 20257:00 amRNSAGM Proceedings
9th Jun 20257:00 amRNSViura Field - Planned Reinstatement of Production
30th May 20257:00 amRNSChange of Registered Office
27th May 20257:00 amRNSFinal Results
2nd May 20257:00 amRNSQ1 2025 Activity Report
29th Apr 20254:42 pmRNSViura Field Update
29th Apr 20257:00 amRNSViura Field Update
123456

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BKY
Berkeley Eng
LSE
0.00%
FSV
Fidelity
LSE
0.12%
GMS
Gulf Marine Services
LSE
-2.49%
BEEP
BEEP.L
LSE
0.00%
RKW
Rockwood Strat.
LSE
0.00%
Trending
MAC
Marechale Cap.
LSE
43.84%
HE1
Helium One
LSE
6.28%
ALRT
Defence Holdings
LSE
-2.38%
NEO
Neo Energy Metals
LSE
-7.30%
IMM
Immupharma
LSE
-5.87%